Methamphetamine and Modulation Functionality of the Prelimbic Cortex for Developing a Possible Treatment of Alzheimer’s Disease in an Animal Model

Methamphetamine and Modulation Functionality of the Prelimbic Cortex for Developing a Possible Treatment of Alzheimer’s Disease in an Animal Model

Alzheimer’s disease (AD) is a progressive neurodegenerative condition that causes cognitive impairment and other neuropsychiatric symptoms. Previously, little research has thus far investigated whether methamphetamine (MAMPH) can enhance cognitive function or ameliorate AD symptoms. This study exami...

Full description

Bibliographic Details
Main Authors: Bai-Chuang Shyu, Zhi-Yue Gao, José Jiun-Shian Wu, Alan Bo Han He, Cai-N Cheng, Andrew Chih Wei Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Aging Neuroscience
Subjects:
methamphetamine (MA)
conditioned taste aversion (CTA)
prelimbic cortex (PrL)
corticosterone (CORT)
Alzeheimer’s disease
rats
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2021.751913/full

Internet

https://www.frontiersin.org/articles/10.3389/fnagi.2021.751913/full

Similar Items